Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Differences in mesenchymal stem cell cytokine profiles between MS patients and healthy donors: implication for assessment of disease activity and treatment.

Journal of neuroimmunology - 13 Aug 2008

Mazzanti Benedetta, Aldinucci Alessandra, Biagioli Tiziana, Barilaro Alessandro, Urbani Serena, Dal Pozzo Simone, Amato Maria Pia, Siracusa Gianfranco, Crescioli Clara, Manuelli Cinzia, Bosi A, Saccardi Riccardo, Massacesi Luca, Ballerini Clara

Abstract excerpt

MSCs have been proposed as possible treatment in MS: In this study MSCs obtained from 10 MS patients and 6 healthy donors (HD) were compared in terms of phenotypical and functional characteristics. We show that MSCs isolated from MS and HD differ significantly for IP10 production. Therefore, alth...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cell Differentiation
Share to Cell Proliferation

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Cytokines

Share to Flow Cytometry

Share to Mesenchymal Stem Cells

Share to Multiple Sclerosis

Share to Receptors, Cytokine

Share to Toll-Like Receptors

Source

Identifiers

PMID: 18562015
DOI: 10.1016/j.jneuroim.2008.05.006

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026. Prepared record publication-18562015-2026-09-02.2. Manifest publication-graph-cohort-2026-09-02.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Differences in mesenchymal stem cell cytokine profiles between MS patients and healthy donors: implication for assessment of disease activity and treatment.PMID 18562015Read ↗

Mesenchymal stem cells modulate IL-17 and IL-9 production induced by Th17-inducing cytokine conditions in autoimmune arthritis: an explorative analysisSemantic proximity Read ↗

Indirect co-cultures of healthy mesenchymal stem cells restore the physiological phenotypical profile of psoriatic mesenchymal stem cells.Semantic proximity Read ↗

The Phenotype and Secretory Activity of Adipose-Derived Mesenchymal Stem Cells (ASCs) of Patients with Rheumatic Diseases.Semantic proximity Read ↗

Cytokine flow cytometry differentiates the clinical status of multiple sclerosis (MS) patients.Semantic proximity Read ↗

The effects of culture-expanded, non-cryopreserved adipose tissue mesenchymal stem cells (AT-MSCs) on neurological and immunological paradigms in females with secondary progressive multiple sclerosis: a phase I/II clinical trialSemantic proximity Read ↗

Alterations of subset and cytokine profile of peripheral T helper cells in PBMCs from Multiple Sclerosis patients or from individuals with MS risk SNPs near genes CYP27B1 and CYP24A1.Semantic proximity Read ↗

Critical roles of TLRs on the polarization of Mesenchymal stem cells for cell therapy of viral infections: A notice for COVID-19 treatmentSemantic proximity Read ↗

Genetic susceptibility to multiple sclerosis in Sardinians: an immunological study.Semantic proximity Read ↗

Potential Therapy for Multiple Sclerosis (MS): Investigating the effects of 1,25-dihydroxycholecalciferol on T regulatory cells in Patients with MSSemantic proximity Read ↗

Characterisation of mesenchymal stem cells from patients with amyotrophic lateral sclerosis.Semantic proximity Read ↗

Cytokine modulation of TLR expression and activation in mesenchymal stromal cells leads to a proinflammatory phenotype.Semantic proximity Read ↗

Toll-like receptor 3 differently modulates inflammation in progressive or benign multiple sclerosis.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.